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Immune factors (e.g., cytokines, chemokines) can alter the activity of neuronal circuits
to promote “sickness behavior,” a suite of adaptive actions that organisms exhibit in
response to infection/injury in order to maximize their chances of recovery (i.e., return to
homeostasis). This includes drastic alterations in sleep/wake states, locomotor activity,
and food intake, among other behaviors. Despite the ample evidence highlighting
interactions between the brain and systemic immunity, studies on how immune
challenges alter the activity of genetically defined cell populations controlling arousal
states are scarce. As the lateral hypothalamus (LH) serves a major integrative function in
behavioral arousal, food intake, and monitoring and responding to changes in systemic
physiology, we investigated how GABAergic neurons within this brain region alter their
activity across normal sleep/wake states and in response to a peripheral immune
challenge with bacterial endotoxin [lipopolysaccharides (LPS)]. Using fiber photometry
(GCaMP6s Ca2+ signal) in tandem with electroencephalogram (EEG)/EMG recordings
to determine arousal states, we observed that population activity of GABAergic neurons
in the lateral hypothalamus (LHGABA) is highest during rapid-eye-movement sleep (REM),
and this activity changes drastically across spontaneous arousal state transitions, with
the lowest activity observed during non-REM sleep. Upon intraperitoneal LPS challenge,
LHGABA neurons rapidly decrease their activity in tandem with elimination of REM sleep
behavior (characteristic of cytokine-induced sickness). Together, these data suggest that
peripheral immune challenges can rapidly (in < 40 min) alter subcortical neuronal circuits
controlling arousal states. Additionally, we demonstrate that fiber photometry offers a
sensitive and cell-type specific tool that can be applied to study the neuronal substrates
of sickness behavior.
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INTRODUCTION
Sickness behavior is characterized by acute and protracted changes in sleep/wake states, appetitive,
sexual, and social behavior, among other changes (Dantzer and Kelley, 2007; Dantzer et al.,
2008; Myers, 2008). This suite of adaptive behaviors is largely conserved across the phylogenetic
tree, including in humans (Shattuck and Muehlenbein, 2015). Changes in behavior in response
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to infection/injury can be attributed to neuroimmune crosstalk
among peripheral and central cytokines, endothelial cells, glia,
and neurons (Henry et al., 2008; Jin et al., 2016). In response
to acute inflammatory challenges, such as bacterial endotoxin
[lipopolysaccharides (LPS)] exposure, mice increase their time
spent in non-rapid-eye-movement (NREM) sleep at the expense
of rapid-eye-movement sleep (REM) sleep, with corresponding
decreases in wakefulness. These inflammatory signals in the
periphery are partially transduced to the brain via vagal afferent
nerve fibers (Opp, 2005; Zielinski et al., 2013; Borniger et al.,
2017). During extended periods of immune activation (e.g., in
neurodegenerative disease), sleep becomes fragmented and is
accompanied by protracted insomnia (Toth and Krueger, 1988;
Dauvilliers, 2007; Irwin and Opp, 2017). The biological substrates
that drive this phenomenon remain to be fully identified and
characterized, although myeloid cell (microglia/macrophage)
interactions with neurons seem to be predominant drivers of
infection-associated sleep disruption (Toth and Hughes, 2004).
Significant progress has been made in recent years in identifying
neural ensembles underlying inflammation-associated changes
in feeding behavior (Chaskiel et al., 2016, 2019; Liu et al.,
2016; Wang et al., 2019). However, additional work is required
to understand how neurons controlling feeding, arousal, and
motivational states integrate various inflammatory inputs to
induce changes in overt behavior.
The first experimental evidence for humoral (and potentially
immune) regulation of sleep/wake states came over a century
ago from the Japanese physiologist Kuniomi Ishimori, who
demonstrated that cerebrospinal fluid (CSF) from sleep-deprived
dogs powerfully induced sleep in naïve recipient dogs (Kubota,
1989; Krueger et al., 2001). Subsequent studies from Fencl et al.
(1971) confirmed this finding by injecting CSF from sleep-
deprived goats into recipient rats and observed marked increases
in sleep. Pappenheimer, Krueger and colleagues subsequently
followed up on these findings and termed the mysterious sleep-
inducing substance in CSF “Factor S.” Factor S was later
determined to be muramyl peptide, a component of bacterial
cell walls. Injections of low doses of muramyl peptide or another
bacterial cell wall component, LPS, powerfully induced slow wave
sleep (SWS) with high amplitude delta (δ) waves (0.5–4 Hz) in
the electroencephalogram (EEG) of cats (Krueger et al., 1982,
1984, 1986; Krueger, 1985; Cady et al., 1989). Why would a piece
of bacterial cell walls have any influence on mammalian sleep?
The evidence thus far supports the hypothesis that the immune
response elicited by a bacterial infection indirectly regulates
the activity of neuronal structures that control sleep/wake
states to putatively overcome the infection/injury and return to
homeostasis. In short, the immune system engages sleep circuitry
in order to promote rest and recovery.
The hypothalamus represents a key biological substrate
underlying the expression of sickness behavior. It controls
virtually all homeostatic processes that become dysregulated
upon infection/injury, including sleep/wake states, food intake,
sexual/social behavior, body temperature, and stress responses,
among others (Saper and Lowell, 2014; Bonnavion et al.,
2016; Scammell et al., 2017). GABAergic neurons within the
lateral division of the hypothalamus (LHGABA) represent a
heterogenous population of cells that differentially contribute
to sleep/wake control. Indeed, single cell RNA sequencing
(scRNA-seq) demonstrated that at least 15 sub-populations
of GABAergic neurons exist within the lateral hypothalamus
(LH) alone (Mickelsen et al., 2019). Major sub-populations
include those that express the long-form leptin receptor
(LepRb), neurotensin (NTS), or cocaine and amphetamine
related transcript (CART) (Bonnavion et al., 2015, 2016;
Mickelsen et al., 2019). Whether these subpopulations play
similar or differing roles in sleep/wake control is an active
area of investigation, but collectively this GABAergic population
seems to promote rapid arousal out of NREM, but not
REM sleep (Herrera et al., 2016; Venner et al., 2016). Early
single-unit electrophysiological studies suggested that LHGABA
neurons are active during sleep, with a large proportion active
during REM states compared to NREM sleep and wakefulness
(Hassani et al., 2010). More recent work demonstrated that
approximately 34% of LHGABA neurons are maximally active
during REM sleep, and function to reinforce and stabilize
hypothalamic representations of feeding behavior (Oesch et al.,
2020). Additionally, early studies suggested that LHGABA neurons
are preferentially responsive to the inflammatory cytokine IL-
1β(De et al., 2002), suggesting that they may play a role in
regulating sickness responses governed by the hypothalamus.
Further, work has demonstrated that sleep deprivation enhances
mRNA expression of a bacterial peptidoglycan recognition
protein (PGRP), suggesting a link between bacteria, the
hypothalamus, and sleep (Rehman et al., 2001). We aimed to
build upon this work by examining population wide LHGABA
Ca2+ activity during spontaneous arousal state transitions and
in response to peripheral endotoxin (LPS) administration. We
hypothesized that LHGABA neurons alter their activity across
discrete brain states and predicted that we would observe
high Ca2+ activity during REM sleep, consistent with prior
observations. Because of the strong REM-suppressive actions of
bacterial endotoxin, we reasoned that LHGABA neurons would




Heterozygous VGAT-IRES-Cre mice (N = 5; male, >8 weeks
old; JAX # 028862) were used in these experiments, housed with
ad libitum food and water at room temperature (22 ± 2◦C).
The dental cement headcap of one mouse became disconnected
(and therefore required euthanasia) between initial recordings
and subsequent LPS experiments, so N = 4 for the LPS
data. These mice were bred in-house and maintained on
the c57bl6 background for >10 generations prior to use.
Cre + mice were used for all experiments, and genotyping was
done using tail gDNA and primers targeting Cre sequences
(Cre_F: GGGATTGCTTATAACACCCTGTTACG; Cre_R:
TATTCGGATCATCAGCTACACCAGAG). All experimental
protocols were approved by the Stanford University IACUC
prior to beginning these studies (protocol #18787).
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Surgery
Electroencephalogram/EMG electrodes were custom made as in
previous work (Carter et al., 2012; Eban-Rothschild et al., 2016,
2020). Mice were deeply anesthetized with ketamine/xylazine
(90 mg kg−1/10 mg kg−1, respectively), and then their head
was shaven and cleaned with betadine/EtOH. Mice were then
positioned on a stereotaxic frame for surgery and administered
prophylactic analgesia (buprenorphine SR; 1 mg kg−1; SC). Mice
were maintained on a low-power heating blanket during surgery
to prevent hypothermia. The skin on the head was cut from the
posterior margin of the eyes until the midpoint of the scapulae,
and then cleaned using H2O2 and sterile saline. Three holes
were drilled into the skull. Two holes (one at 1.5 mm AP, 1 mm
ML; the other on the contralateral hemisphere at −2 mm AP,
−1.5 mm ML) were to be used for placement of cortical electrodes
for EEG measurement, and the last hole was used for viral
injections into the LH (−1.2 mm AP, ± 0.89 mm ML, −5.3 mm
DV). A Hamilton syringe (0.36 mm outer diameter; 28 gauge)
loaded with 300 nl AAV-DJ-DIO-ef1α-GCaMP6s [titer > 1 × 10
(Dauvilliers, 2007) vg/ml; Stanford Viral Vector Core] was slowly
lowered to these coordinates and virus was injected unilaterally
at 100 nl/min. Following injection, the syringe was left in place
for an additional 10 min to prevent backflow, then the syringe
was slowly removed. A 400 µm diameter fiber optic (Doric
Lenses; 6 mm in length) was slowly lowered to just above the
virus injection coordinate (−5.2 mm DV) and then cemented
into place using Metabond (Parkell, Inc.) and UV-curable dental
resin. EMG leads were inserted and secured in the trapezius
muscles, and EEG screws were cemented into place. After fiber
and EEG/EMG placement, any surgical openings were sutured
closed, and then the mice were given supplemental warmth
(heating pad) and hydration (0.4 ml saline, SC) until mobile.
Mice were allowed to recover for at least 3 weeks before starting
experiments (to allow for adequate transgene expression). Before
starting recordings, mice were separated and allowed to acclimate
to a specialized (open top) sleep recording chamber, EEG/EMG
tethers, and the fiber optic patchcord for at least 3 days.
LPS Administration
Mice were administered 0.5 mg kg−1 LPS (serotype O111:B4;
Sigma-Aldrich) in sterile saline (intraperitoneal; IP) as in prior
work (Borniger et al., 2017) at zeitgeber time (ZT) 4, when
sleep pressure has mostly abated. Forty minutes later, photometry
and EEG signals were collected for an additional 40 min to
monitor LHGABA Ca2+ activity in tandem with sleep/wake states.
For control/baseline recordings, mice were administered sterile
saline vehicle alone (200 µl; IP). We chose to record 40 min
after IP injections to reduce the influence stress had on the
neural/sleep phenotype.
Fiber Photometry
Fiber photometry is an increasingly common method within the
neuroscience community by which an optic fiber is placed near
a brain region of interest and light is delivered and collected
from the fiber tip. Cells within the target area are engineered
(e.g., via viral transfection) to express a fluorescent protein (e.g.,
GCaMP6s) that, upon light excitation, transduces Ca2+ activity
(a proxy of neural activation) into a high-temporal resolution
fluorescent signal that is collected by the optic fiber, converted
into a voltage signal, and subsequently analyzed. Because of the
small and lightweight design of optic fibers, these recordings can
be done in freely moving mice, as in the present study. In line with
this, fiber photometry experiments were conducted as previously
(Eban-Rothschild et al., 2016; Giardino et al., 2018; Li et al., 2020).
In brief, we modulated blue light from a 470-nm excitation LED
(M470F3, ThorLabs, NJ, United States) at 211 Hz, using a custom
MATLAB program (MathWorks, Natick, MA, United States) and
a multifunction data acquisition device (NI USB-6259, National
Instruments, Austin, TX, United States). Blue light was passed
through a GFP excitation filter (MF469-35, ThorLabs), bounced
off a dichroic mirror (MD498, ThorLabs), and then coupled using
a fiber collimation package (F240FC-A, ThorLabs) into a low-
fluorescence patch cord (400 µm, 0.48 NA; Doric Lenses) via
a zirconia sleeve (Doric). GCaMP6s fluorescence was collected
through the excitation patch cord, where it traveled through a
GFP emission filter (MF525-39, ThorLabs), and focused onto a
photodetector with a lens (Model 2151, Newport, Irvine, CA,
United States; LA1540-A, ThorLabs). The signal was relayed
to a lock-in amplifier (30-ms time constant, Model SR830,
Stanford Research Systems, Sunnyvale, CA, United States) that
was synchronized to 211 Hz. Amplified signals were collected
at 1 kHz using custom MATLAB code and a multifunction data
acquisition device (National Instruments).
EEG/EMG
Sleep/wake states were assessed via EEG/EMG. These
biopotentials were sampled at 256 Hz with VitalRecorder
(Kissei Comtec Co.) software, and then passed through an
amplifier (Grass Instruments). Raw EEG/EMG voltage data
were exported (.txt) into MATLAB (MathWorks, Natick, MA,
United States) and analyzed using custom scripts [as in Li et al.
(2020)]. Wake was defined as low amplitude, high frequency
EEG oscillations with prominent EMG signal. NREM sleep was
characterized by large amplitude, low frequency delta oscillations
in the EEG, with little or no EMG signal. REM sleep was
identified based on a predominant theta (θ) component of the
EEG, with no EMG activity reflecting complete motor atonia.
Behavioral states (wake, NREM, or REM sleep) were assessed
blind to the time-locked photometry signal or experimental
manipulation (LPS or saline).
Histology
After completion of experiments, mice were deeply anesthetized
using ketamine/xylazine and then perfused (transcardial) with
ice-cold 1x PBS followed by 4% paraformaldehyde (PFA). Brains
were dissected and post-fixed in 4% PFA at 4◦C overnight,
followed by cryoprotection in 30% sucrose for 2–3 days until
sunk. Serial sections were cut on a cryostat (Leica Microsystems)
at 30 µm and placed into 24-well plates containing 1x PBS+ 0.1%
NaN3, covered with aluminum foil, and maintained at 4◦C until
histology/immunohistochemistry. Validation of GCaMP6s viral
transduction and fiber placement was confirmed via confocal
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microscopy (Excitation λ: 488 nm; Emission λ: 509 nm; LSM-
710; Zeiss).
Data Analysis and Statistics
Electroencephalogram/EMG data and time-locked photometry
data were analyzed using custom MATLAB code. In brief,
photometry data was corrected for linear or exponential decay
in the trace [as in Eban-Rothschild et al. (2016) and Eban-
Rothschild et al. (2020)], which occurred in a minority of
recordings. Photometry data was down sampled to 256 Hz in
order to match the EEG signal sampling rate. Data from each
arousal state transition (i.e., wake-to-NREM, NREM-to-wake,
NREM-to-REM, and REM-to-Wake) were analyzed for the mean
and max fractional fluorescence change (dF/F) in each state,
and then time series were generated for 10 s preceding and
10 s following each transition. Differences among experimental
groups was assessed using one-way ANOVA, followed by Tukey’s
HSD post hoc test. For analysis of GCaMP6s spectral data, 2-
way repeated measures ANOVAs were used with treatment and
frequency bin as independent factors, followed by Šidák’s multiple
comparisons post hoc test.
RESULTS
LHGABA Neurons Are Predominantly
REM-Active
We monitored LHGABA Ca2+ activity during natural arousal
state transitions. These neurons exhibited marked changes in
GCaMP fluorescence across arousal states, with the highest
mean fractional fluorescence change (1F/F or dF/F) during
REM sleep compared to wakefulness or NREM sleep (Figure 1).
Additionally, these neurons were intermediately active during
wakefulness compared to REM and NREM sleep, respectively
(Figure 1D; One-way ANOVA F2,591 = 438.1; p < 0.0001; Tukey’s
post hoc wake vs. NREM: q = 10.72, adjusted p < 0.0001; wake
vs. REM: q = 35.58, adjusted p < 0.0001; NREM vs. REM:
q = 41.84, adjusted p < 0.0001). In contrast, NREM sleep and
wakefulness showed similar maximal 1F/F values, but REM sleep
reached upward of 20–30% 1F/F state (Figure 1E; One-way
ANOVA F2,591 = 212.9; p < 0.0001); (Tukey’s post hoc wake
vs. REM: q = 27.29, adjusted p < 0.0001; NREM vs. REM:
q = 28.45, p < 0.0001). These results indicate that LHGABA
Ca2+ activity peaks during REM sleep, suggesting that this
FIGURE 1 | Lateral hypothalamic GABAergic neurons are wake- and REM sleep-active. (A) Heatmaps showing GCaMP6s signal across arousal state transitions
(Wake-to-NREM (256 transitions), NREM-to-Wake (n = 208 transitions), NREM-to-REM (n = 60 transitions), and REM-to-Wake (n = 57 transitions), with transition
number on the y-axis and time on the x-axis; GCaMP6s signal is reflected in the colormap. (B) The same data as in panel (A) but collapsed into the average signal
time series across arousal state transitions. (C) Experimental design describing the set up for simultaneous recording of EEG/EMG + fiber photometry signal from
freely moving mice. (D) mean dF/F of LHGABA neuronal activity per bout of each arousal state (One-way ANOVA F2,591 = 438.1; p < 0.0001); (Tukey’s post hoc wake
vs. NREM: q = 10.72, adjusted p < 0.0001; wake vs. REM: q = 35.58, adjusted p < 0.0001; NREM vs. REM: q = 41.84, adjusted p < 0.0001). (E) max dF/F of
LHGABA neuronal activity per bout of each arousal state (One-way ANOVA F2,591 = 212.9; p < 0.0001); (Tukey’s post hoc wake vs. REM: q = 27.29, adjusted
p < 0.0001; NREM vs. REM: q = 28.45, p < 0.0001). Error bars represent S.E.M., N = 5 mice, ****p < 0.0001, One-way ANOVA followed by Tukey’s HSD post hoc
test).
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heterogenous subset of neurons likely plays a role in REM sleep-
related phenomena.
Endotoxin Rapidly Silences LHGABA
Neurons
Upon injection of LPS, mice rapidly entered NREM sleep at
the expense of REM sleep. This was associated with widespread
silencing of LHGABA neurons throughout the entire recording
session (Figures 2A–D; mean dF/F per bout between baseline and
LPS groups (wakefulness: t-ratio = 8.239, adjusted p < 0.0001;
NREM sleep: t-ratio = 6.057, p < 0.0001); max dF/F per bout
between baseline and LPS groups (NREM sleep: t = 4.020,
p < 0.001) (Multiple t-tests, Holm–Sidak method). Upon closer
inspection of the data, we noted that the GCaMP6s signal
showed reductions primarily in the lower frequency ranges
(<10 Hz), where large, coordinated bursts of calcium activity
(and putatively neuronal activity) occur (Figures 2E,F; 2-way RM
ANOVA main effect of LPS treatment F1,6 = 11.85, p = 0.0138;
main effect of frequency F240,1440 = 24.74, p < 0.0001; interaction
of treatment × frequency F240,1440 = 11.44, p < 0.0001). Šidák’s
multiple comparisons post hoc tests identified all frequency
bins below 4.25 Hz were significantly different between groups
(0.25 Hz frequency steps; Figure 2F). There was no compensation
in higher frequency ranges, suggesting the effect we observed
was due to a reduction in coordinated firing rather than simple
desynchronization of the local LHGABA network. These data link
inflammation-induced suppression of REM sleep to the silencing
of hypothalamic neurons that regulate arousal states.
DISCUSSION
Our experiments identify LHGABA neurons as putative central
sensors of peripheral immune activation. We observed that
LHGABA neurons are primarily REM-active, an arousal state
powerfully inhibited by acute immune challenge (i.e., with LPS).
Prior work demonstrated that these neurons are integrated into
arousal circuitry in a unique way. Optogenetic stimulation of
LHGABA neurons during NREM, but not REM sleep, rapidly
induces wakefulness (Herrera et al., 2016). This aligns with our
observations of maximal LHGABA Ca2+ activity during REM
sleep, which may represent a physiological “ceiling” that further
optogenetic stimulation cannot break.
GABAergic neurons in the lateral hypothalamus provide
powerful inhibitory control over GABAergic neurons within
the thalamic reticular nucleus (TRN). Direct activation of TRN
neurons results in diverse electrocortical and behavioral outputs,
which are largely dependent on the stimulation frequency and
modality (e.g., electrical vs. optical). These effects range from
FIGURE 2 | LPS rapidly silences LHGABA neurons. (A) Representative GCaMP6s trace and scaleogram from a mouse 40 min following a saline injection. The trace is
shaded by the arousal state the animal was in at the time (based on EEG/EMG recordings), where blue = NREM sleep, red = REM sleep, and white = wakefulness.
The colormap for the scaleogram represents the power. (B) representative GCaMP6s trace and scaleogram from the same mouse 40 min following a 0.5 mg kg-1
LPS IP injection. Note the absence of high amplitude GCaMP signal in tandem with loss of REM sleep. (C) quantification of all data in the experimental set showing
the mean dF/F per bout between baseline and LPS groups (wakefulness: t-ratio = 8.239, adjusted p < 0.0001; NREM sleep: t-ratio = 6.057, p < 0.0001).
(D) quantification of all data in the experimental set showing the max dF/F per bout between baseline and LPS groups (NREM sleep: t = 4.020, p < 0.001) (Multiple
t-tests, Holm–Sidak method). (E) Mean spectral power of the GCaMP6s signal among the entire experimental set for saline and LPS treated mice. Note the disparity
in power at the lower (<10 Hz) frequencies. (F) The same data as in panel (E) except the difference is calculated for ease of viewing (2-way RM ANOVA main effect
of LPS treatment F1,6 = 11.85, p = 0.0138; main effect of frequency F240,1440 = 24.74, p < 0.0001; interaction of treatment × frequency F240,1440 = 11.44,
p < 0.0001; individual data points were analyzed using post hoc Sidak’s multiple comparisons test (significance denoted by **** where all values are significant until
4.25 Hz on the x-axis). Note a ∼80% decrease in low frequency power in response to LPS treatment. Error bars represent S.E.M., ****p < 0.0001, ***p < 0.001, and
**p < 0.01; N = 4 mice.
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increases in cortical gamma (∼30–150 Hz) (Macdonald et al.,
1998), NREM spindles (Halassa et al., 2011; Kim et al., 2012),
and EEG slow waves (Kim et al., 2012). A few years ago, Herrera
et al. (2016) identified LHGABA neurons as a major source of
inhibitory input to TRNGABA neurons, directly linking a feed
forward inhibitory circuit to dynamic changes in behavior and
cortical activity. This positioned LHGABA neurons as major
players in sleep/wake state transitions and overall arousal state.
Our data extend these findings and suggest that immune-
mediated modulation of this neuronal population may play a
role in the regulation of arousal in response to infection/injury,
although this remains to be tested empirically. It is relevant that
other hypothalamic populations, including the sleep-regulating
preoptic neurons, seem to be disposable in mediating the
effect of inflammation (muramyl dipeptide) on sleep (Shoham
et al., 1989). This lends credence to the idea that discrete cell
populations within this brain structure enact a coordinated
response to inflammatory signals, rather than a general and
non-specific response.
Another major aspect of sickness is a change in the expression
of motivated behavior (Lasselin et al., 2017), which is naturally
intertwined with arousal. An important characteristic of a
motivational state is that it competes with other motivational
states for behavioral output. The normal expression of behavior
re- quires a hierarchical organization of motivational states that is
continuously updated according to the circumstances. When an
infection occurs, the sick individual is at a life or death juncture
and his/her physiology and behavior must be altered so as to
overcome the disease. However, this is a relatively long-term
process that needs to make room for more urgent needs when
necessary. It is easy to imagine the following [from Dantzer
(2001)]: “if a sick person lying in his/her bed hears a fire alarm
ringing in his/her house and sees flames and smoke coming
out of the basement, he/she should be able to momentarily
overcome his/her sickness behavior to escape danger”(Dantzer,
2001). In motivational terms, fear competes with sickness, and
fear-motivated behavior takes precedence over sickness behavior.
An example of this competition between fear and sickness is
provided by the observation that the depressing effects of IL-1β
on behavior of mice are more pronounced when experimental
animals are tested in the safe surroundings of their home cage
than when they are placed into a new environment (Propes and
Johnson, 1997; Dantzer, 2001). As LHGABA neurons regulate
diverse motivated behaviors, in part via their projections to the
midbrain dopaminergic system (Nieh et al., 2016), future work
should examine how inflammatory signaling alters their activity
across various motivational states.
Our findings on LHGABA dynamics during immune challenge
are especially relevant given the role these neurons play in
appetitive and consummatory behaviors dysregulated during
sickness. Seminal studies from the middle of the 20th
century revealed that electrical stimulation of the LH (and
putatively GABA neurons) promotes voracious feeding and
appetitive reward-related behaviors (Hoebel and Teitelbaum,
1962; Margules and Olds, 1962), while lesioning this area elicited
aphagia and subsequent emaciation (Anand and Brobeck, 1951;
Hoebel, 1965). Subsequent work demonstrated that the actions
of the LH on consummatory/appetitive behavior are conserved
across evolutionary time and persist in humans (Quaade et al.,
1974; Molina-Borja and Gómez-Soutullo, 1989). Stuber and
colleagues used cell-type specific tools to bolster these early
findings and identified LHGABA neurons as major drivers of
feeding and reward behavior (Jennings et al., 2015). Optogenetic
stimulation of these neurons (20 Hz) increased the time mice
spent in a designated food area, enhanced food consumption, and
promoted a preference for the location that was previously paired
with food consumption. Reciprocally, photoinhibition of these
neurons elicited opposite phenotypes, where mice reduced food
consumption and time spent in a location paired with optical
inhibition. Appetitive and consummatory behaviors toward food
are powerfully suppressed during immune activation (O’Reilly
et al., 1988; Langhans et al., 1990), and hypophagia/anorexia is a
hallmark of sickness behavior (Dantzer and Kelley, 2007; Pecchi
et al., 2009). Our data support the notion that LHGABA neurons
are critical regulators of sickness-induced sleep. However, it
remains to be determined whether this same cell population
links immune activation to reductions in food intake. If true,
augmentation of LHGABA activity may ameliorate several aspects
of sickness behavior.
Our study has a few key limitations that are worth
discussing. We did not measure EEG/EMG and photometry
signals during the entire course of LPS-induced sickness (up
to 24 h). This was done due to the potential of constant
illumination to photobleach the GCaMP reporter, which would
prevent appropriate interpretation of the data. Therefore, it
remains unclear whether LHGABA neurons recover their normal
activity prior to the resolution of overt sickness behavior.
Additionally, we cannot make causal inferences from these data,
as the contributions of other neuronal populations on LHGABA
neuronal activity and sleep/wake states was not eliminated (e.g.,
hypocretin/orexin neurons) (Bonnavion et al., 2015). Indeed,
LPS was shown to powerfully suppress hypocretin/orexin and
histaminergic neuronal activity (cFos immunolabeling) during
the dark phase in rats, when wakefulness and cellular activity
are highest (Gaykema and Goehler, 2009). Comparative studies
in mice with intact hypocretin/orexin neurons and those lacking
this cellular population (ataxin-3 mice) demonstrated that
LPS powerfully inhibited hypothalamic hypocretin expression
in both genotypes but was only completely abolished in
ataxin-3 mice. LPS also suppressed a potential compensatory
increase in histamine decarboxylase-positive cells within the
hypothalamus of ataxin-3 mice, which implies the involvement
of multiple neuromodulator systems in inflammation-associated
sickness (Tanaka et al., 2016). A major caveat that may
influence the conclusions that we draw from these data are
that bulk photometry recordings cannot delineate whether
LPS silenced all LHGABA neurons equally [as there are many
subtypes (Mickelsen et al., 2019)], or whether their firing
rates were fundamentally unchanged and simply desynchronized
in their output. However, spectral analysis of the GCaMP
signal (Figure 2) suggests that LPS reduced low frequency/high
amplitude calcium waves, without additional increases in
higher frequency oscillations, suggesting a net reduction in
coordinated neuronal output rather than desynchronization.
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Subsequent miniscope or single unit electrophysiological studies
will be needed to definitively answer these questions. We also
did not measure the extent of neuroinflammation induced by
the fiber optic surgery itself, which may have influenced the
somnogenic and neuromodulatory properties of LPS. In line with
this, to provide a comprehensive picture of LHGABA responses to
LPS, multiple doses should be used in future studies. Finally, the
downstream outputs of these neurons driving sickness behavior
was not examined, and the effects of LHGABA neurons may
be secondary to a different population within the LH or other
nuclei. Viral-mediated tract tracing studies and genetic ablation
techniques will help to answer these questions.
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